Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.
Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.
The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.
Publications found:
1,734
Sort by:
Epiomic Epidemiology Series: Thyroid Cancer Forecast in 17 Major Markets 2015-2025
US$ 6,382.00
... from the proprietary Epiomic patient segmentation database. To ... registries, clinical trials and epidemiology studies. All of the ... Thyroid Cancer’s incident population. Examination of the incidence of the different causative gene mutations for Thyroid Cancer. Identify sub-populations within Thyroid Cancer ...
December 2015
66 pages
Epiomic Epidemiology Series: Testicular Cancer Forecast in 20 Major Markets 2015-2025
US$ 6,382.00
... from the proprietary Epiomic patient segmentation database. To ... patient registries, clinical trials and epidemiology studies. All of the ... Testicular Cancer’s incident population. Examination of various elevated serum levels present in Testicular Cancer patients. Identify sub-populations within Testicular Cancer ...
December 2015
54 pages
Global - Cancer Vaccines Market and Pipeline Vaccines Analysis to 2020
US$ 1,290.00
... Cancer Vaccines Market to 2020 I. Provenge 3. Cancer Vaccines Market - Regional Analysis to 2020 I. United States - Cancer Vaccines Market II. Europe - Cancer Vaccines Market III. Asia - Cancer Vaccines Market 4. Global Cancer Vaccines Market - Major Deals 5. Global Cancer Vaccines - Funding 6. Global Cancer ...
November 2015
213 pages
2016 Global Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies - France, Germany, Italy, Japan, Spain, UK, US
US$ 27,800.00
... and market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological ...
November 2015
1200 pages
2016 Europe Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies - France, Germany, Italy, Spain, UK
US$ 15,760.00
... and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market ... of the disease. During the next five years, the European cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological ...
November 2015
820 pages
2016 Global Cancer Diagnostics Market: Emerging Tests, Technology Assessment, Instrumentation Review, Country Volume and Sales Forecasts, Strategic Profiles of Leading Suppliers
US$ 6,000.00
... cancer diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers. The report presents: Estimated numbers of cancer ... significance and market needs for both current and emerging cancer diagnostic tests, as well as listings of companies, universities and research centers developing or marketing new ...
November 2015
510 pages
2016 Future Horizons and Growth Strategies in the Italian Hospital Tumor Marker Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities
US$ 3,080.00
This new report from VPGMarketResearch contains 525 pages, 38 tables, and presents a comprehensive analysis of the Italian hospital tumor marker testing market, including: Major issues pertaining to the Italian hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...
November 2015
525 pages
2016 Future Horizons and Growth Strategies in the Japanese Hospital Tumor Marker Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities
US$ 3,880.00
This new report from VPGMarketResearch contains 537 pages, 42 tables, and presents a comprehensive analysis of the Japanese hospital tumor marker testing market, including: Major issues pertaining to the Japanese hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...
November 2015
537 pages
2016 Future Horizons and Growth Strategies in the Spanish Hospital Tumor Marker Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities
US$ 3,080.00
This new report from VPGMarketResearch contains 521 pages, 41 tables, and presents a comprehensive analysis of the Spanish hospital tumor marker testing market, including: Major issues pertaining to the Spanish hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...
November 2015
521 pages
2016 Future Horizons and Growth Strategies in the US Hospital Tumor Marker Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities
US$ 5,200.00
This new report from VPGMarketResearch contains 567 pages, 50 tables, and presents a comprehensive analysis of the US hospital tumor market testing market, including: Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with ...
November 2015
567 pages
2016 Future Horizons and Growth Strategies in the UK Hospital Tumor Marker Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities
US$ 3,080.00
This new report from VPGMarketResearch contains 527 pages, 37 tables, and presents a comprehensive analysis of the UK hospital tumor marker testing market, including: Major issues pertaining to the UK hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological ...
November 2015
527 pages
2016 Future Horizons and Growth Strategies in the UK Tumor Marker Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities
US$ 5,440.00
Complete report $5,400. DataPack (test volumes, sales forecasts, supplier shares) $1,950. Highlights Comprehensive 575-page analysis of the UK tumor marker testing market. Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological trends ...
November 2015
575 pages
2016 Future Horizons and Growth Strategies in the Global Tumor Marker Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities
US$ 27,800.00
... segmentation analysis, including reviewof the market dynamics, structure, size, growth and major suppliersby country. Cancer statistics, etiology and recent ... current and emerging tumor markers, including: Biochemical Markers Oncogenes Growth Factors Hormones Colony Stimulating Factors Lymphokines Immunohistochemical Stains, and ...
November 2015
1200 pages
Global Prostate Cancer Therapeutics Market to 2020
US$ 1,200.00
... Decapeptyl 4. Eligard 5. Vantas 6. Leuplin Anti–Androgens 1. Casodex 2. Xtandi or MDV3100 3. Xtandi US or MDV3100 2. Global Prostate Cancer Chemotherapy Drugs Market 1. Taxotere 2. Jevtana 3. Global Prostate Cancer Immunotherapy Drugs Market– 1. Provenge 4. Global Prostate Cancer Targeted Therapy Drugs Market ...
November 2015
80 pages
KOL Insight: Prostate Cancer: Competition intensifies in race to the top
US$ 7,900.00
... Benefits Understand the Unique Benefits of KOL Insight: Prostate cancer Prostate Cancer: Competition intensifies in race to the top examines the most prominent insights gained from the field’s key ... performance of companies with the most robust new product pipelines Prostate Cancer: Competition intensifies in race to the top answers key questions including: How ...
November 2015
142 pages
Prostate Cancer: KOL Insight
US$ 7,495.00
... for market share? Prostate Cancer: KOL Insight looks at the future of prostate cancer therapy and provides insight from 12 leading North American and European KOLs. How will marketed ... co-administration a competitive disadvantage? And could it play a role in metastatic hormone-naïve prostate cancer? Pipeline Therapies Apalutamide (JNJ-927/ARN-509; Johnson & Johnson ...
November 2015
-
2016 World Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices - Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 27,600.00
... by country, section, market segment, and can be custom-tailored to your specific information needs and budget. '2016 World Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs ... and market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the ...
October 2015
1200 pages
2016 Italy Cancer Diagnostics Market Segmentation Analysis: Hospitals, Commercial Labs - Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 5,360.00
... report is available by section, market segment, and can be custom-tailored to your specific information needs and budget. '2016 Italy Cancer Diagnostics Market Segmentation Analysis: Hospitals, Commercial ... markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the ...
October 2015
570 pages
2016 US Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices - Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 7,840.00
... is available by section, market segment, and can be custom-tailored to your specific information needs and budget. '2016 US Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs ... markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the ...
October 2015
620 pages
